Clinical trials in Long Branch, NJ

8 recruiting studies have a site in or near Long Branch, NJ, New Jersey.

Top conditions here

All conditions

Showing 8 of 8 studies

RecruitingPhase 2NCT05554393

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Sponsor: National Cancer Institute (NCI)

Basking Ridge, NJ · Livingston, NJ · Long Branch, NJ · +172 more sites

RecruitingPhase 2NCT06317649

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Sponsor: National Cancer Institute (NCI)

Basking Ridge, NJ · Livingston, NJ · Long Branch, NJ · +222 more sites

RecruitingPhase 2NCT06672146

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Sponsor: National Cancer Institute (NCI)

Basking Ridge, NJ · Livingston, NJ · Long Branch, NJ · +132 more sites

RecruitingPhase 3NCT05879926

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Sponsor: NRG Oncology

Camden, NJ · Cherry Hill, NJ · Elizabeth, NJ · +1223 more sites

RecruitingPhase 3NCT05812807

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Sponsor: Alliance for Clinical Trials in Oncology

Camden, NJ · Cherry Hill, NJ · Elizabeth, NJ · +825 more sites

RecruitingPhase 2 / Phase 3NCT03851445

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Sponsor: SWOG Cancer Research Network

Basking Ridge, NJ · Holmdel, NJ · Lakewood, NJ · +1226 more sites

RecruitingPhase 2NCT05806931

Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer

Sponsor: Rutgers, The State University of New Jersey

Elizabeth, NJ · Jersey City, NJ · Lakewood, NJ · +6 more sites

RecruitingPhase 2NCT05559164

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

Sponsor: Rutgers, The State University of New Jersey

Elizabeth, NJ · Hamilton, NJ · Jersey City, NJ · +7 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.